Monday, September 23, 2019
- 1:45pm-3:15pm
-
Homozygous BZRAP1 mutations cause autosomal recessive dystonia
Genetics · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Homozygous Huntington’s disease with two reduced penetrance alleles: A Case Report
Huntington’s Disease · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Huntington Disease-Like 2: A Case Presentation and Review of the Literature
Choreas (Non-Huntington’s Disease) · Les Muses, Level 3
- 1:45pm-3:15pm
-
Huntington’s Disease Protein Huntingtin Associates with its own mRNA
Huntington’s Disease · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Huntington’s Disease presenting as sporadic cerebellar ataxia
Ataxia · Les Muses, Level 3
- 1:45pm-3:15pm
-
Huntington’s disease: A case review of Sub-Saharan Africans with diverse origins
Huntington’s Disease · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Hydralazine protects nigrostriatal dopaminergic neurons from MPP+ and MPTP induced neurotoxicity: Roles of Nrf2-ARE signaling pathway
Neuropharmacology · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Hyperammonemic Encephalopathy as Primary Cause of Movement Disorders: Report of Two Cases
Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Hyperkinetic Movement Disorders in Congenital Disorders of Glycosylation
Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Hypophosphatasia presenting as parkinsonism with compound heterozygous mutations in ALPL gene
Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3
- «Previous Page
- 1
- …
- 32
- 33
- 34
- 35
- 36
- …
- 75
- Next Page»